TABLE 2.

Latex assay reactivity with nonleptospirosis case specimens

Group of specimensCondition or discharge diagnosis of patientaNo. of specimens from patients with condition or diagnosisNo. (%) of specimens positive by latex assay
BankedMeningococcal disease10
    specimenHIV60
    panelToxoplasmosis20
Legionellosis10
Brucellosis61 (16.7)
Syphilis80
Viral hepatitis169 (56.3)
Malaria84 (50.0)
Melioidosis51 (20.0)
Dengue242 (8.3)
ANCA81 (12.5)
ANA93 (33.3)
Hantaviral infection50
Lyme disease51 (20.0)
Cytomegalovirus42 (50.0)
Epstein-Barr virus41 (25.0)
BarbadosAseptic meningitis10
    prospectiveBacterial sepsis130
    hospital-basedToxoplasmosis20
    studyAtypical pneumonia40
Obstructive jaundice40
Alcoholic hepatitis30
Viral hepatitis170
Rhabdomyolysis20
Gastroenteritis60
Dengue110
Hematologic conditions60
Guillain-Barré syndrome10
Undifferentiated viral illness150
Toxic shock syndrome10
Bacterial endocarditis10
Others (medical/surgical)213 (14.3)
  • a HIV; human immunodeficiency virus; ANCA, antinuclear antibodies; ANA, antineutrophil cytoplasmic antibodies.